DNA Script extends Series B

Paris-based DNA Script, a DNA synthesis company, has raised $50 million as an extension to its Series B funding, expanding the round to $89 million.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this